NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock

Retrieved on: 2021-04-22 11:15:00

Tags for this article:

Finance

Initial public offering

Forward-looking statement

Corporate finance

U.S. Securities and Exchange Commission

Prospectus

Shelf registration

Public offering

NeuBase Therapeutics Inc.

Click the tags to see associated articles and topics

NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock. View article details on hiswai:

Excerpt

All of the shares of common stock in the offering are being sold by NeuBase. RBC Capital Markets, Oppenheimer & Co. Inc. and Chardan are acting as ...

Article found on: finance.yahoo.com

View Original Article